Accelerate to discover
Related topics
Why ventilator so important in the battle against COVID-19?
Sep 21, 2020
The COVID-19 has caused shortages of medical devices in many countries, especially ventilators. Many companies around...
Imaging Performance of a multimodal module to enhance preclinical irradiator capabilities
Sep 15, 2020
Upgrading an existing irradiator with such a multi-modal imaging device is a reasonable investment in laboratories...
Are you still using traditional methodologies for your Oncology cell metabolism studies?
Sep 10, 2020
In this infographic, learn about the challenges experienced by scientists in analysing cellular metabolism and how...
Using DNA repair and machine learning to improve cancer risk prediction
Sep 7, 2020
Across the world, breast cancer continues to be the leading type of cancer in women, accounting for 25% of all cases....
Quantitative evaluation of pulmonary function with hyperpolarized xenon gas MR
Aug 20, 2020
Hyperpolarized 129Xe MR has been proven to be a powerful tool to evaluate the pulmonary function and has been widely...
Applications of Hyperpolarized 129Xe MRI for functional imaging of the lungs
Aug 11, 2020
2015 marked the first ever translation of hyperpolarized gas MRI to diagnostic clinical practice. Research at the...
Detection of Rare Cells and Circulating Tumor Cells using NovoCyte flow cytometer
Aug 11, 2020
Circulating tumor cells (CTC) are rare cells shed from a solid tumor or metastases that circulate through the...
Introducing Amnis AI Image Analysis software
Aug 4, 2020
Amnis AI Image Analysis Software combines the power of high dimensional data reduction with artificial intelligence,...
Aug 7, 2018
LSD1 is a flavin adenine dinucleotide (FAD)-dependent homolog of the amine oxidase family and there was recently brought attention to it as a potential therapeutic target. The interest came from an observation of unusually high expression of LSD1 in certain types of poor-prognosis cancers. It was previously thought that LSD1 removes monomethyl and dymethyl histone marks. However, recently it was showed that it interacts with multiple transcripton factor. This raised a possibility of other drugs being used.
New inhibitor ORY-1001 was succesfully tested on LSD1 and blast cell differentioation was observed. The flow cytometric testing on this experiment was done with Novocyte. ORY-1001 disrupts the protein interaction between LSD1 and GFI1.
Related technologies: Conventional flow cytometry
Get more info
Brand profile
ACEA manufactures xCELLigence impedance-based, label-free, real time cell analysis system and NovoCyte flow cytometers.
More info at:
www.aceabio.com
BioFocus newsletter
Register to receive Brand new technology development, Important product updates, Interesting scientific events and more!
BioTech a.s. © 2014
Designed & developed by imagineit
Technologies
